引用本文:赖彦华,李甲志,杨建荣.器官移植受者新型冠状病毒感染诊治的研究进展[J].中国临床新医学,2023,16(10):990-994.
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 192次   下载 547 本文二维码信息
码上扫一扫!
分享到: 微信 更多
器官移植受者新型冠状病毒感染诊治的研究进展
赖彦华,李甲志,杨建荣
530021 南宁,广西壮族自治区人民医院(广西医学科学院)移植科(赖彦华,李甲志),肝胆胰脾外科(杨建荣)
摘要:
[摘要] 器官移植受者由于长期服用免疫抑制药,是重型或危重型新型冠状病毒感染的高危人群,重症率和病死率高于普通人群。探讨器官移植受者新型冠状病毒感染诊治进展对提高患者救治水平有重要意义。因此,该文就器官移植受者新型冠状病毒感染的流行病学、临床特点、防治措施等方面作一综述。
关键词:  器官移植  新型冠状病毒  临床特点  疫苗  治疗
DOI:10.3969/j.issn.1674-3806.2023.10.02
分类号:R 617
基金项目:广西卫生健康委科研课题(编号:Z-A20230079)
Research progress in diagnosis and treatment of COVID-19 in organ transplant recipients
LAI Yan-hua, LI Jia-zhi,YANG Jian-rong
Department of Transplantation, the People′s Hospital of Guangxi Zhuang Autonomous Region(Guangxi Academy of Medical Sciences), Nanning 530021, China
Abstract:
[Abstract] Due to long-term use of immunosuppressive drugs, organ transplant recipients are at high risk of serious or critical coronavirus disease 2019(COVID-19), and their incidence rate of severe cases and mortality rate are higher than those of a general population. It is of great significance to explore the research progress in diagnosis and treatment of COVID-19 in organ transplant recipients for improving the rescue level of the patients. Therefore, this paper reviews the epidemiology, clinical characteristics, prevention and treatment measures of COVID-19 in organ transplant recipients.
Key words:  Organ transplantation  Severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)  Clinical characteristics  Vaccine  Treatment